Fred’s Inc. added two more board directors as the company awaits word from the Federal Trade Commission on the fate of Rite Aid’s sale to Walgreens Boots Alliance.
Fred's Inc. (FRED) posted decent fourth-quarter fiscal 2016 results on the back of strategic initiatives, strong holiday season sales and improving Pharmacy business.
Rite Aid Corporation (RAD) is slated to report fourth-quarter fiscal 2017 results on Apr 25.
The Zacks Analyst Blog Highlights: Amazon, Celgene, Facebook and Walgreens Boots
Top Research Reports for Today: AMZN, CELG, FB, WBA
Options traders are pricing in a big move for Rite Aid (RAD) shares as it has huge implied volatility.
Fred's, Inc. (FRED) posted narrower-than-expected losses in fourth-quarter fiscal 2016. However, sales lagged the Zacks Consensus Estimate.
If the Federal Trade Commission approves Rite Aid’s sale to Walgreens Boots Alliance, Fred’s Inc. plan to become a national player in the U.S. pharmacy business gets a major boost.
Fred’s Inc. said it remains committed to buying up to 1,200 Rite Aids in order to help Walgreens Boots Alliance and Rite Aid win Federal Trade Commission approval of their merger.
Walgreens Boots Alliance, Inc. (WBA) reported adjusted earnings per share (EPS) of $1.36 in second-quarter fiscal 2017, up 6.1% year over year.
Walgreens Boots Alliance CEO Stefano Pessina said Wednesday he was “still optimistic” the company would be successful completing its acquisition of Rite Aid and divest hundreds of stores to Fred's Inc.
Discount retailer Fred's Inc. (FRED) has recently slipped to the red. The shares of the company have declined 16% in the past one year, underperforming the Zacks categorized Retail-Discount industry's gain of 8%.